In this issue of JAMA Cardiology, Gaudino et al 1 published a retrospective analysis of the Arterial Revascularization Trial, evaluating specifically the influence of method of harvest of the internal thoracic artery (ITA) on outcomes after coronary artery bypass grafting (CABG). Surprisingly, patients who had a skeletonized ITA did slightly worse than if the standard pedicled ITA was used. If the ITA is harvested as a pedicled graft, it is taken off the chest wall together with the associated fat and veins and part of the endothoracic fascia, while with the skeletonized method only the artery is separated from the chest wall, sparing some of the vascular supply to the chest wall. One may ask, "Why is this potentially important?" To answer that question, it may be helpful to provide a brief history of CABG.The first successful CABG operation was performed by Kolesov in Russia in 1965, 2 and Loop and colleagues 3 demonstrated that patients who underwent CABG with an ITA graft had an improvement in long-term survival compared with patients receiving only saphenous vein grafts. It is now well accepted that the use of at least 1 ITA markedly improves outcome after CABG and it is a quality metric for cardiac surgeons, although this issue has never been the subject of a randomized trial.A corollary of this concept is that if 1 ITA is good, 2 would be better. The use of 2, or bilateral ITAs (BITA), was first described by Suzuki et al 4 in 1973. Many studies [5][6][7][8] have reported that patients who received CABG with BITA grafts do better than if they receive a single ITA (SITA) graft. After all, this seems to be common sense, that patients who receive BITA or multiple arterial grafts would have improved outcomes. However, patients who receive a BITA CABG have a trend toward increased sternal wound infection, although this has been debated.Nearly all studies comparing BITA with SITA have been unmatched or propensity-matched studies. Propensitymatched, retrospective studies do provide valuable information when prospective, randomized trials are not available, but factors that are not taken into account may bias the results and conclusions. For example, retrospective propensity-matched studies generally do not take into consideration the quality of bypass targets, frailty, or the potential for compliance with measures of secondary prevention. These factors have a marked effect on long-term outcome after CABG and are taken into consideration in a prospective, randomized trial. Despite many retrospective analyses showing superior outcomes when BITA CABG is performed, the use of BITAs did not catch on like the